Page 27 - Research Models News Today

Mitsubishi UFJ Kokusai Asset Management Co. Ltd. increased its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) by 5.0% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 37,341 shares of the medical research company’s stock after buying an additional […]

StockNews.com upgraded shares of Charles River Laboratories International (NYSE:CRL – Get Rating) from a hold rating to a buy rating in a research note published on Thursday. Several other research firms have also issued reports on CRL. Credit Suisse Group cut their price target on Charles River Laboratories International from $280.00 to $260.00 and set […]

Oppenheimer Asset Management Inc. trimmed its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) by 0.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 41,853 shares of the medical research company’s stock after selling […]

Wrapmanager Inc. reduced its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) by 19.5% in the 4th quarter, Holdings Channel reports. The fund owned 1,479 shares of the medical research company’s stock after selling 359 shares during the period. Wrapmanager Inc.’s holdings in Charles River Laboratories International were worth $322,000 as of […]

Raymond James Trust N.A. lowered its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) by 11.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,089 shares of the medical research company’s stock after selling 138 […]

Mesirow Institutional Investment Management Inc. increased its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) by 19.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 13,940 shares of the medical research company’s stock after acquiring an additional […]

Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) dropped 6.3% during trading on Tuesday . The stock traded as low as $190.44 and last traded at $190.91. Approximately 449,221 shares changed hands during mid-day trading, a decline of 18% from the average daily volume of 544,679 shares. The stock had previously closed at $203.83. […]

Fisher Asset Management LLC raised its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) by 4.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 251,140 shares of the medical research company’s stock after acquiring an additional 10,381 […]

Curi Wealth Management LLC grew its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) by 53.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 56,151 shares of the medical research company’s stock after acquiring an additional 19,642 […]

New Mexico Educational Retirement Board lowered its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) by 7.7% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,400 shares of the medical research company’s stock after selling 200 shares […]